Literature DB >> 20119896

[Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection].

C Sarrazin1, T Berg, R S Ross, P Schirmacher, H Wedemeyer, U Neumann, H H Schmidt, U Spengler, S Wirth, H H Kessler, M Peck-Radosavljevic, P Ferenci, W Vogel, D Moradpour, M Heim, M Cornberg, U Protzer, M P Manns, W E Fleig, M M Dollinger, S Zeuzem.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20119896     DOI： 10.1055/s-0028-1110008

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN： 0044-2771            Impact factor:   2.000


× No keyword cloud information.
  50 in total

1.  [Diagnostic and interventional abdominal ultrasonography].

Authors:  A Potthoff; M J Gebel; K Rifai
Journal:  Internist (Berl)       Date:  2012-03       Impact factor: 0.743

2.  Which is the IDEAL peginterferon for Hepatitis C: a meta-analysis of both pegylated interferons in the treatment of HCV-infected patients.

Authors:  Frank Tacke
Journal:  Hepat Mon       Date:  2010-09-01       Impact factor: 0.660

3.  Age-related differences in response to peginterferon alfa-2a/ribavirin in patients with chronic hepatitis C infection.

Authors:  Claudia Roeder; Sabine Jordan; Julian Schulze Zur Wiesch; Heike Pfeiffer-Vornkahl; Dietrich Hueppe; Stefan Mauss; Elmar Zehnter; Sabine Stoll; Ulrich Alshuth; Ansgar W Lohse; Stefan Lueth
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

Review 4.  [Personalized treatment of viral hepatitis of the present and the future : Hepatitis B, C, delta, and E].

Authors:  R Bartenschlager; M Cornberg; T Pietschmann
Journal:  Internist (Berl)       Date:  2017-07       Impact factor: 0.743

Review 5.  Treatment Options in Hepatitis C.

Authors:  Stefan Zeuzem
Journal:  Dtsch Arztebl Int       Date:  2017-01-09       Impact factor: 5.594

6.  Development of a second version of the Cobas AmpliPrep/Cobas TaqMan hepatitis C virus quantitative test with improved genotype inclusivity.

Authors:  Johannes Vermehren; Giuseppe Colucci; Peter Gohl; Nabila Hamdi; Ahmed Ihab Abdelaziz; Ursula Karey; Diana Thamke; Heike Zitzer; Stefan Zeuzem; Christoph Sarrazin
Journal:  J Clin Microbiol       Date:  2011-07-13       Impact factor: 5.948

Review 7.  [New direct-acting antiviral agents for the treatment of chronic hepatitis C in 2014].

Authors:  M Cornberg; C Höner zu Siederdissen; B Maasoumy; M P Manns
Journal:  Internist (Berl)       Date:  2014-04       Impact factor: 0.743

8.  The management of needlestick injuries.

Authors:  Heiko Himmelreich; Holger F Rabenau; Matthias Rindermann; Christoph Stephan; Markus Bickel; Ingo Marzi; Sabine Wicker
Journal:  Dtsch Arztebl Int       Date:  2013-02-01       Impact factor: 5.594

9.  Evaluation of liver tissue by ultrasound elastography and clinical parameters in children with multiple blood cell transfusions.

Authors:  Georg W Wurschi; Karim Kentouche; Karl-Heinz Herrmann; Ines Krumbein; Mariana Nold; James F Beck; Jürgen R Reichenbach; Hans-Joachim Mentzel
Journal:  Pediatr Radiol       Date:  2019-03-29

Review 10.  The etiology, diagnosis and prevention of liver cirrhosis: part 1 of a series on liver cirrhosis.

Authors:  Johannes Wiegand; Thomas Berg
Journal:  Dtsch Arztebl Int       Date:  2013-02-08       Impact factor: 5.594
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.